BLEND LABS INC

Blend Labs’ insider sell reveals strategic risk‑management, not panic—an insightful look at how executives balance gains amid a volatile mortgage‑tech market.

Blend Labs insider sale by Head Nima Ghamsari signals confidence, not distress—monitor upcoming product launches and earnings for upside potential.

Haveli’s latest buy of 17.4 million Blend Labs shares at $1.44 shows insider confidence in its mortgage‑tech upside, sparking a modest price lift and social‑media buzz.

Insider Oxana Tkach’s recent 21,209‑share sale of Blend Labs’ Class A stock at $1.45 highlights ongoing liquidity moves amid a steep 56.8% YTD decline—what it means for investors.

Insider sale by Blend Labs’ Head of Revenue signals cautious optimism amid falling stock—watch earnings, Autopilot launch and external buys for future upside.

Haveli Investments’ latest buy of Blend Labs shares signals “buy‑the‑dip” confidence, hinting at a potential rebound driven by a new Q2 Software partnership.

Blend Labs insider selling amid a bullish trend: a Rule 10b5‑1 plan sale by the principal accounting officer shows mixed confidence while the stock rebounds—what does it mean for investors?

Haveli Investments’ steady buying of Blend Labs shares signals long‑term confidence in its mortgage fintech platform and potential upside amid a volatile market.

Blend Labs insider Oxana Tkach sells 5,625 shares at $1.59, reflecting cautious portfolio moves amid a steep stock decline and mixed executive activity.

Blend Labs insider selling sparks caution: Principal Accounting Officer trades 2,500 shares near a 52‑week low, while institutional buying signals long‑term upside.